`G2216` Home supply inject naloxon

Take-home supply of injectable naloxone (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure

Medicare coverage: Carrier judgment
Status: active (October 2026 file)

Medicare pricing for G2216

Physician Fee Schedule (CY 2026, RVU26D)

Status X: statutory exclusion, not paid under the PFS.

Payer policies and prior authorization for G2216

Payer coverage policies that name G2216

G2216 appears in 1 coverage policy from Blue Cross & Blue Shield of Rhode Island.

Payer	Policy	Role in policy	Reviewed	Document
Blue Cross & Blue Shield of Rhode Island	Opioid Treatment Program MEDICAL COVERAGE POLICY \| 2	covered if criteria are met		payer document

Medicaid fee-for-service

Prior authorization required or conditional in IN.

KS: $16.50 (default), effective Jan 1, 2026
MS: $11.11 (comprehensive), effective Jul 1, 2026
ND: $0.00 (physician), effective Aug 1, 2026
VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.

G2216 Home supply inject naloxon